Concepedia

Publication | Open Access

Cyclin D1 Overexpression and Response to Bortezomib Treatment in a Breast Cancer Model

65

Citations

34

References

2006

Year

Abstract

Cyclin D1 repression of STAT3 expression may explain the association between cyclin D1 overexpression and improved outcome in breast cancer. In addition, bortezomib can amplify the proapoptotic function of cyclin D1, raising the possibility that cyclin D1 levels may be a marker for predicting the response to this novel drug.

References

YearCitations

1998

2.1K

2001

2K

1999

1.6K

2006

1.1K

1997

918

2002

891

1997

745

1994

678

1996

659

2003

584

Page 1